Rarecells Holdings, Inc., a pioneering force in the biotechnology sector, is headquartered in the United States. Founded in 2014, the company has rapidly established itself as a leader in the development of innovative solutions for cancer diagnostics and personalised medicine. With a focus on rare cell detection and analysis, Rarecells Holdings offers unique products and services that enhance the accuracy of cancer detection, setting them apart in a competitive market. The company operates primarily in North America and Europe, leveraging advanced technologies to provide cutting-edge tools for researchers and clinicians. Rarecells Holdings has achieved significant milestones, including the introduction of its proprietary CTC (circulating tumour cell) isolation technology, which has garnered recognition for its effectiveness and reliability. As a result, Rarecells Holdings continues to solidify its position as a key player in the biotechnology industry, committed to advancing cancer care through innovation.
How does Rarecells Holdings, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Rarecells Holdings, Inc.'s score of 3 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Rarecells Holdings, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to address carbon emissions at this time. In the context of climate action, it is essential for organisations to set measurable targets and report emissions transparently. Without such data or commitments, Rarecells Holdings, Inc. may face challenges in aligning with industry standards for sustainability and climate responsibility. As the global focus on reducing carbon footprints intensifies, the absence of emissions data and reduction initiatives could impact the company's reputation and stakeholder trust.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Rarecells Holdings, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
